Consensus Becton, Dickinson and Company London S.E.

Stocks

0R19

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - London S.E. 16:30:01 01/10/2026 +03			After hours 21:26:31
179.11 ^USD	-1.44%		178.07	-0.58%

09-21	Becton, Dickinson Names Arthur Hu Chief Information, Digital Officer	MT
09-21	Becton, Dickinson and Company Announces Appointment of Arthur Hu as Executive Vice President and Chief Information and Digital Officer, Effective September 30, 2026	CI

173df8.hRFWMXopMtf5OlChnOliRbd3lKHLcqNQbpgUo_GuGdE.53U1CSpkbZiIaGSTr6wKDe1E98j_ENIDGM96z7PqVrjAZRl-KH9t4bFjaA~95edf6809c200665fa80fe74584aab40

Analysts' recommendations: Becton, Dickinson and Company

08-31	BofA Adjusts Price Target on Becton Dickinson and Co. to $200 From $185	MT
08-13	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
08-13	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT
08-13	RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating	MT
08-12	UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating	MT
08-07	Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161	MT
08-07	Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190	MT
08-07	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198	MT
08-07	Piper Sandler Adjusts Price Target on Becton Dickinson and Co. to $175 From $161	MT
08-07	JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175	MT
08-07	RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating	MT
08-05	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $182 From $163	MT
07-28	UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target	MT
07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-09	Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says	MT
07-06	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190	MT
06-12	BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177	MT
05-27	Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating	MT
05-08	Becton, Dickinson Building Growth After 'Clean' Fiscal Q2 Beat, RBC Says	MT
05-07	Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $190 From $180	MT
05-07	Stifel Nicolaus Adjusts Becton, Dickinson and Company Price Target to $175 From $215	MT
05-04	TD Cowen Adjusts Price Target on Becton, Dickinson and Company to $163 From $189, Maintains Hold Rating	MT
05-04	U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower	RE
04-17	Piper Sandler Adjusts Becton, Dickinson and Company PT to $159 From $170, Maintains Neutral Rating	MT
04-14	RBC Cuts Price Target on Becton, Dickinson to $175 From $195, Keeps Sector Perform Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
BECTON, DICKINSON AND COMPANY	-	-	-	-
ABBOTT LABORATORIES				+21.69%
MEDTRONIC PLC				+21.49%
STRYKER CORPORATION				+33.56%
ESSILORLUXOTTICA				+59.76%
CENCORA, INC.				+22.98%
BECTON, DICKINSON AND COMPANY				+9.31%
HOYA CORPORATION				+28.07%
IDEXX LABORATORIES, INC.				+34.31%
DEXCOM, INC.				+9.49%
Average				+26.74%
Weighted average by Cap.				+27.51%